Context Therapeutics Inc Stock Ownership - Who owns Context Therapeutics?

Insider buying vs selling

Have Context Therapeutics Inc insiders been buying or selling?
Martin A. LehrChief Executive Officer2023-02-215,823$0.84
Martin A. LehrChief Executive Officer2023-02-135,606$0.87
Martin A. LehrChief Executive Officer2023-02-065,040$0.97
Martin A. LehrChief Executive Officer2023-01-307,027$0.70
Martin A. LehrChief Executive Officer2023-01-236,839$0.72
Martin A. LehrChief Executive Officer2023-01-176,783$0.74
Jennifer Lynn MinaiazaryChief Financial Officer2022-12-1625,000$0.74
Martin A. LehrChief Executive Officer2022-12-1620,000$0.74
Alex C. LevitChief Legal Officer Corp. Sec2022-12-096,000$0.85
Martin A. LehrChief Executive Officer2022-08-1913,000$1.85

1 of 2

CNTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CNTX insiders and whales buy or sell their stock.

CNTX Shareholders

What type of owners hold Context Therapeutics Inc stock?
Martin A. Lehr6.14%979,891$862.30kInsider
Vanguard Group Inc3.59%573,400$504.59kInstitution
Hightower Advisors LLC0.79%125,852$110.75kInstitution
Bridgeway Capital Management LLC0.66%105,809$93.11kInstitution
Mill Creek Capital Advisors LLC0.66%104,631$92.08kInstitution
Alex C. Levit0.39%61,983$54.55kInsider
Geode Capital Management LLC0.37%59,568$52.42kInstitution
Evan G. Dick0.35%56,373$49.61kInsider
Two Sigma Investments LP0.35%55,688$49.01kInstitution
Virtu Financial LLC0.26%41,191$36.25kInstitution

1 of 3

CNTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CNTX8.06%7.22%Net Buying
TCON10.51%89.49%Net BuyingNet Buying
PHGE13.82%34.65%Net SellingNet Buying
INFI21.48%22.42%Net Buying
ACGN0.18%99.82%Net BuyingNet Selling

Context Therapeutics Stock Ownership FAQ

Who owns Context Therapeutics?

Context Therapeutics (NASDAQ: CNTX) is owned by 8.06% institutional shareholders, 7.22% Context Therapeutics insiders, and 84.72% retail investors. Martin A. Lehr is the largest individual Context Therapeutics shareholder, owning 979,891.00 shares representing 6.14% of the company. Martin A. Lehr's Context Therapeutics shares are currently valued at $862.30k.

If you're new to stock investing, here's how to buy Context Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.